聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 52 分钟 35 秒 前

Allergan Receives CHMP Positive Opinion For ENZEPI(R) (Pancrelipase) For Patients With Exocrine Pancreatic Insufficiency (EPI)

周五, 04/29/2016 - 18:32
Significant step to bringing this effective therapy to EPI patients in the 28 countries of the EU Specifically formulated to meet the CHMP guidelines on lipase enzyme activity ensuring no-overfill leading to accuracy and consistency of dosing Further...
Biopharmaceuticals, Regulatory
Allergan, ENZEPI, Pancrelipase, Exocrine Pancreatic Insufficiency

Stryker’s Spine Division Debuts 3D-Printed Tritanium(R) Posterior Lumbar Cage at AANS Meeting

周五, 04/29/2016 - 18:18
Proprietary Tritanium Technology, in Spinal Applications, Is Designed for Bone In-Growth & Enhanced Biological Fixation ALLENDALE, N.J.--(Healthcare Sales & Marketing Network)--Stryker’s Spine division will introduce the Tritanium Posterior Lumbar (PL) ...
Devices, Orthopaedic, Neurosurgery, Product Launch
Stryker, Tritanium, Lumbar Cage, spinal fusion

Wenzel Spine Announces Commercial Launch of the VariLift(R)-LX

周五, 04/29/2016 - 13:47
Company Continues Expansion of Expandable Stand-Alone Portfolio AUSTIN, Texas--(Healthcare Sales & Marketing Network)--Wenzel Spine, Inc., a pioneer medical device company focused on providing minimally invasive, expandable stand-alone alternatives to t...
Devices, Orthopaedic, Neurosurgery, Product Launch
Wenzel Spine, VariLift-LX, interbody fusion device, spine surgery

Elekta's Latest Monaco Release Features Up to Four Times Faster Calculation Speed for Reduced Radiotherapy Planning Times

周五, 04/29/2016 - 13:20
Monaco 5.11 makes debut at ESTRO 35 in Italy TURIN, Italy, April 29, 2016 -- (Healthcare Sales & Marketing Network) -- Elekta is pleased to announce that Monaco® version 5.11, the latest update to its industry-leading treatment planning software, i...
Devices, Oncology, Product Launch
Elekta, treatment planning, Monaco, VMAT, radiosurgery, radiotherapy

Pliant Therapeutics Expands Leadership Team

周四, 04/28/2016 - 14:30
Appoints Three Seasoned Executives to Advance Therapies to Prevent or Reverse Fibrotic Diseases REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--Pliant Therapeutics, Inc., a company focused on discovering, developing and commercializing bre...
Biopharmaceuticals, Personnel
Pliant Therapeutics, fibrotic disease

Varian Gives European Clinicians First Glimpse of Next Big Advance in Radiotherapy at ESTRO 35

周四, 04/28/2016 - 14:23
TURIN, Italy, April 28, 2016 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems will demonstrate its full range of radiotherapy delivery systems at the 35th ESTRO (European Society for Radiotherapy and Oncology) meeting, taking place here...
Devices, Oncology
Varian Medical Systems, radiotherapy, radiosurgery, High Definition Radiotherapy

Abbott to Acquire St. Jude Medical

周四, 04/28/2016 - 13:56
COMBINATION WILL CREATE A PREMIER MEDICAL DEVICE LEADER AND STRENGTHEN ABBOTT'S LONG-TERM GROWTH POTENTIAL Acquisition will enhance Abbott's global scale and capabilities and will further diversify its portfolio of best-in-class products and revenue sou...
Devices, Cardiology, Mergers & Acquisitions
Abbott, St. Jude Medical

Study Shows Minute Ventilation Preferred Over End-Tidal CO(2) In Monitoring For Life-Threatening Opioid Induced Respiratory Depression

周四, 04/28/2016 - 13:43
WALTHAM, Mass., April 28, 2016 -- (Healthcare Sales & Marketing Network) -- Respiratory Motion, Inc. – Research presented at The Deutsche Anesthesia Congress (DAC) Shows Minute Ventilation Monitoring may be preferable to indirect measurement using EtCO2, ...
Devices, Monitoring
Respiratory Motion Inc, Minute Ventilation Monitoring

Teleflex Signs New Agreements with HealthTrust for LMA(R) Airways and Arrow(R) Pain Management Solutions

周四, 04/28/2016 - 13:36
WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical technologies for critical care and surgery, has announced its Anesthesia Division has signed two new group purchasing agreements with Heal...
Devices, Group Purchasing
Teleflex, HealthTrust, LMA Airways, Cuff Pilot

Healthcare Entrepreneur Greg Serrao Joins Summit Partners as Executive-in-Residence

周三, 04/27/2016 - 15:57
BOSTON, MA--(Healthcare Sales & Marketing Network) - Summit Partners, a global growth equity investor, today announced the addition of Greg Serrao to the firm's Executive-in-Residence ("EIR") program. In this role, Mr. Serrao will work closely wi...
Devices, Venture Capital, Personnel
Summit Partners

Proton Therapy Center Initiates 3D Image Guided Proton Therapy to Enhance Precision of Cancer Care

周三, 04/27/2016 - 15:53
PALO ALTO, Calif., April 27, 2016 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (VAR), today announced that its 3D volumetric imaging technology is now being used at a California proton therapy center to enhance the precision and qua...
Devices, Oncology
Varian Medical Systems, ProBeam, proton therapy, radiotherapy

RhythMedix(R) exceeds first year projections; monitors over 23,000 patients on innovative RhythmStar(R) Remote Cardiac Monitoring System

周三, 04/27/2016 - 15:50
Product commercialization strengthened by litigation patent defense insurance policy MOUNT LAUREL, N.J., April 27, 2016 -- (Healthcare Sales & Marketing Network) -- RhythMedix, a privately held wireless medical monitoring company focused on transformin...
Devices, Cardiology, Monitoring
RhythMedix, RhythmStar, cardiac monitor

MedDay Appoints Catherine Moukheibir as Chairman of its Board of Directors

周三, 04/27/2016 - 15:45
PARIS, April 27, 2016 -- (Healthcare Sales & Marketing Network) -- MedDay, a biotechnology company focused on the treatment of nervous system disorders, today announces the appointment of Catherine Moukheibir as Chairman of its Board of Directors. Cath...
Biopharmaceuticals, Neurology, Personnel
MedDay, multiple sclerosis

Novartis Receives Three FDA Breakthrough Therapy Designations for IlaristTo Treat Rare Types of Periodic Fever Syndromes

周三, 04/27/2016 - 15:40
Subject to approvals, Ilaris® (canakinumab) will likely be first FDA-approved treatment for TRAPS and HIDS/MKD, and an important alternative treatment for patients with FMF Designations support potential expedited review of Ilaris to help address th...
Biopharmaceuticals, FDA
Novartis, Ilaris, Periodic Fever Syndrome

Intuity Medical Receives FDA Clearance to Market POGO(R) Automatic(TM) Blood Glucose Monitoring System

周二, 04/26/2016 - 13:36
POGO is the first glucose meter and multi-test cartridge that combines lancing, sample collection and analysis into easy, one-step testing without the need for separate strips and lancets SUNNYVALE, Calif., April 26, 2016 -- (Healthcare Sales & Marketin...
Diagnostics, Devices, Monitoring, Endocrinology, FDA
Intuity Medical, POGO , Blood Glucose Monitor, diabetes

MD Anderson Cancer Center to Acquire Elekta Linear Accelerators and Other Radiotherapy Solutions

周二, 04/26/2016 - 13:27
HOUSTON, Texas, April 26, 2016 -- (Healthcare Sales & Marketing Network) -- The University of Texas MD Anderson Cancer Center has signed a deal with Elekta (EKTA-B.ST) to acquire Elekta Infinity™ linear accelerators, brachytherapy afterloaders as well as ...
Devices, Oncology
Elekta, Infinity, linear accelerator, brachytherapy, radiotherapy

Hematogenix Laboratory Services, LLC (Hematogenix)- Announces the Launch of two U.S. Food and Drug Administration (FDA) Approved PD-L1 Companion Diagnostic Tests to Help Guide Oncologists Using Immuno-Oncology Therapies

周二, 04/26/2016 - 13:23
TINLEY PARK, Ill., April 25, 2016 -- (Healthcare Sales & Marketing Network) -- Hematogenix, an industry leader in the field of integrated pathology services for drug development and clinical testing, announces the availability of the FDA approved PD-L1 co...
Diagnostics, Oncology, Product Launch
Hematogenix Laboratory Services, PD-L1, KEYTRUDA, OPDIVO

Astellas Announces Key Leadership Appointments in Ethics and Compliance and US Legal Organizations

周二, 04/26/2016 - 13:15
NORTHBROOK, Ill., April 25, 2016 -- (Healthcare Sales & Marketing Network) -- Astellas today announced key leadership appointments in its Ethics and Compliance and US Legal departments, taking effect April 25. Mark Wanda will join the Ethics and Compli...
Biopharmaceuticals, Personnel
Astellas

Aralez Receives Health Canada Approval For BLEXTEN(TM)

周一, 04/25/2016 - 13:34
MILTON, Ontario, April 25, 2016 -- (Healthcare Sales & Marketing Network) -- Aralez Pharmaceuticals Inc. (ARLZ) (ARZ.TO) ("Aralez" or the "Company"), a global specialty pharmaceutical company, today announced the Health Canada approva...
Biopharmaceuticals, Regulatory
Aralez Pharmaceuticals, BLEXTEN, bilastine, Seasonal Allergic Rhinitis

Celator(R) Pharmaceuticals Announces Positive Results Demonstrating Reduced Healthcare Resource Use with VYXEOS(TM) Compared to Standard Treatment for Acute Myeloid Leukemia (AML)

周一, 04/25/2016 - 13:24
Phase 2 study results presented at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting EWING, N.J., April 25, 2016 -- (Healthcare Sales & Marketing Network) -- Celator Pharmaceuticals, Inc. (CPXX) today announced that patients treated in a Phase...
Biopharmaceuticals, Oncology
Celator Pharmaceuticals, VYXEOS, acute myeloid leukemia

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong